The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Open accessAbstract
This review summarizes an expanding body of knowledge indicating that failure to resolve inflammation and altered immune processes underlie the development of pulmonary arterial hypertension. The chemokines and cytokines implicated in pulmonary arterial hypertension that could form a biomarker platform are discussed. Pre-clinical studies that provide the basis for dysregulated immunity in animal models of the disease are reviewed. In addition, we present therapies that target inflammatory/immune mechanisms that are currently enrolling patients, and discuss others in development. We show how genetic and metabolic abnormalities are inextricably linked to dysregulated immunity and adverse remodeling in the pulmonary arteries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation is a prominent feature of PH that may be mediated by the host-microbe interaction[314,315].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [314]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Fatal primary pulmonary hypertension in a 30‐yr-old female with APECED syndrome
Korniszewski, L., Kurzyna, M., Stolarski, B., et al. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00018203 · Cited by 19
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 17
Perivascular Fibrosis of Muscular Pulmonary Arteries in Chronic Obstructive Pulmonary Disease
Andoh, Y., Shimura, S., Aikawa, T., Sasaki, H., & Takishima, T. (1992) · CHEST Journal · doi:10.1378/chest.102.6.1645 · Cited by 17
[Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
Tabata, T., Ono, S., Song, C., et al. (1997) · PubMed · Cited by 17
Rabieyousefi, M., Soroosh, P., Satoh, K., et al. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-67 · Cited by 15
Effects of TNF-alpha blockade in monocrotaline-induced pulmonary hypertension.
Henriques‐Coelho, T., Brandão-Nogueira, A., Moreira‐Gonçalves, D., et al. (2008) · PubMed · Cited by 14
Curing HIV-associated pulmonary arterial hypertension: Figure 1–
Tcherakian, C., RIVAUD, E., Zucman, D., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00138211 · Cited by 10
Quinlan, T. R., Laubach, V. E., Zhou, N., et al. (1998) · CHEST Journal · doi:10.1378/chest.114.1_supplement.53s · Cited by 10
Cras, T. D. L., Tyler, R. C., Horan, M. P., et al. (1998) · CHEST Journal · doi:10.1378/chest.114.1_supplement.35s-a · Cited by 9
Tu, L., Huertas, A., Fadel, É., et al. (2012) · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1229 · Cited by 7
Counting techniques in morbid anatomy.
Ms, D. (1972) · PubMed · Cited by 6
Flagged first, then by citations
Cited by
Sorted by citations
Autophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
Hypoxia-inducible factor signaling in pulmonary hypertension
Pullamsetti, S. S., Mamazhakypov, A., Weissmann, N., Seeger, W., & Savai, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137558 · Cited by 234
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186
Pulmonary arterial hypertension and the Enigma code of smouldering inflammation
Gomez-Arroyo, J., Abbate, A., & Voelkel, N. F. (2016) · European Respiratory Journal · doi:10.1183/13993003.00996-2016 · Cited by 8
Metadata
- Authors
- Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R.
- Affiliations
- Université Paris-Sud (FR)
- Venue
- Circulation Research
- Published
- 2014-06-20
- Volume
- 115
- Issue
- 1
- Pages
- 165-175
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC4097142
- OpenAlex
- W2132001965
- Cited by
- 1,029
- References
- 211
- Citations by year
- 2026: 78 · 2025: 84 · 2024: 114 · 2023: 84 · 2022: 102 · 2021: 141 · 2020: 92 · 2019: 101 · 2018: 68 · 2017: 60 · 2016: 62 · 2015: 34 · 2014: 6
- FWCI
- 43.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-12-JSV1-0004)
- National Institutes of Health (5r01hl074186-17, 5p01hl108797-10)
- National Heart, Lung, and Blood Institute (HL082662, R01-HL074186, R01HL095686, R56HL082662, R01HL082662, P01-HL-108797)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- pulmonary arterial hypertension, inflammation, immune dysregulation, chemokines, cytokines, biomarkers, animal models, anti-inflammatory therapy, pulmonary vascular remodeling, genetic abnormalities, metabolic abnormalities
- MeSH terms
- Animals, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Humans, Hypertension, Pulmonary, Immunity, Inflammation, Lymphocytes, Macrophages, Biomarkers, Cytokines, Chemokines, Familial Primary Pulmonary Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
